Study title:
Blood. 2005 Aug 15;106(4):1376-81. Epub 2005 Apr 28.
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in
aggressive lymphoma: an early prognostic tool for predicting patient outcome.
Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, Gaulard P, Garderet L,
Lepage E, Reyes F, Meignan M.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|